Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 2
1947 2
1950 2
1952 1
1955 1
1958 4
1960 1
1961 2
1962 1
1963 3
1964 3
1965 4
1966 1
1967 1
1968 1
1969 2
1970 1
1971 2
1972 1
1979 1
1981 1
1983 1
1985 4
1986 5
1987 13
1988 4
1989 7
1990 4
1991 1
1992 5
1993 5
1994 5
1995 4
1996 5
1997 5
1998 12
1999 18
2000 21
2001 20
2002 20
2003 21
2004 23
2005 17
2006 24
2007 21
2008 23
2009 23
2010 33
2011 26
2012 22
2013 25
2014 33
2015 23
2016 26
2017 22
2018 23
2019 14
2020 12
Text availability
Article attribute
Article type
Publication date

Search Results

582 results
Results by year
Filters applied: . Clear all
Page 1
Perioperative management of Parkinson's disease.
Akbar U, Kurkchubasche AG, Friedman JH. Akbar U, et al. Among authors: friedman jh. Expert Rev Neurother. 2017 Mar;17(3):301-308. doi: 10.1080/14737175.2017.1241143. Epub 2016 Oct 3. Expert Rev Neurother. 2017. PMID: 27677316 Review.
Updating the recommendations for treatment of tardive syndromes: A systematic review of new evidence and practical treatment algorithm.
Bhidayasiri R, Jitkritsadakul O, Friedman JH, Fahn S. Bhidayasiri R, et al. Among authors: friedman jh. J Neurol Sci. 2018 Jun 15;389:67-75. doi: 10.1016/j.jns.2018.02.010. Epub 2018 Feb 5. J Neurol Sci. 2018. PMID: 29454493
Recent developments in drug-induced movement disorders: a mixed picture.
Factor SA, Burkhard PR, Caroff S, Friedman JH, Marras C, Tinazzi M, Comella CL. Factor SA, et al. Among authors: friedman jh. Lancet Neurol. 2019 Sep;18(9):880-890. doi: 10.1016/S1474-4422(19)30152-8. Epub 2019 Jul 3. Lancet Neurol. 2019. PMID: 31279747 Review.
Tardive dyskinesia: Epidemiology.
D'Abreu A, Akbar U, Friedman JH. D'Abreu A, et al. Among authors: friedman jh. J Neurol Sci. 2018 Jun 15;389:17-20. doi: 10.1016/j.jns.2018.02.007. Epub 2018 Feb 5. J Neurol Sci. 2018. PMID: 29433811 Review.
Valbenazine-induced parkinsonism.
Akbar U, Kim DS, Friedman JH. Akbar U, et al. Among authors: friedman jh. Parkinsonism Relat Disord. 2020 Jan;70:13-14. doi: 10.1016/j.parkreldis.2019.11.021. Epub 2019 Nov 25. Parkinsonism Relat Disord. 2020. PMID: 31785443 No abstract available.
Pimavanserin for Parkinson's Disease psychosis: Effects stratified by baseline cognition and use of cognitive-enhancing medications.
Espay AJ, Guskey MT, Norton JC, Coate B, Vizcarra JA, Ballard C, Factor SA, Friedman JH, Lang AE, Larsen NJ, Andersson C, Fredericks D, Weintraub D. Espay AJ, et al. Among authors: friedman jh. Mov Disord. 2018 Nov;33(11):1769-1776. doi: 10.1002/mds.27488. Epub 2018 Nov 2. Mov Disord. 2018. PMID: 30387904 Free PMC article. Clinical Trial.
Apathy.
Friedman JH. Friedman JH. R I Med J (2013). 2018 Aug 1;101(6):9-10. R I Med J (2013). 2018. PMID: 30068044 No abstract available.
Pharmacological interventions for psychosis in Parkinson's disease patients.
Friedman JH. Friedman JH. Expert Opin Pharmacother. 2018 Apr;19(5):499-505. doi: 10.1080/14656566.2018.1445721. Epub 2018 Mar 1. Expert Opin Pharmacother. 2018. PMID: 29494265 Review.
Tardive Syndromes.
Friedman JH. Friedman JH. Continuum (Minneap Minn). 2019 Aug;25(4):1081-1098. doi: 10.1212/CON.0000000000000754. Continuum (Minneap Minn). 2019. PMID: 31356294 Review.
Malingering?
Friedman JH. Friedman JH. R I Med J (2013). 2017 May 1;100(5):8-9. R I Med J (2013). 2017. PMID: 28459913 No abstract available.
582 results
Jump to page
Feedback